Table 1.
Omics type | Technology | Reference |
---|---|---|
| ||
Genomics | DNA microarray | [31] |
DNA-sequencing | [32] | |
Epigenomics | DNA methylation | [38] |
Chromatin immunoprecipitation (ChIP)-sequencing | [39] | |
Assessment of accessible regions (e.g. using DNase-sequencing or ATAC-sequencing) | [40,41] | |
Transcriptomics | Microarray | [51] |
RNA-sequencing | [51] | |
Proteomics | Mass spectrometry (MS) | [58] |
Immunoaffinity (antibody-based) assay | [59] | |
Metabolomics | Nuclear magnetic resonance (NMR) | [60,61] |
Mass spectrometry (MS) | [60] | |
Microbiome | 16S rRNA sequencing | [67] |
Shotgun metagenomic sequencing | [68] | |
Cell subsets | Flow cytometry | [69] |
Mass cytometry | [70] | |
Immune functions | Ex-vivo stimulation of immune cells | [71,79] |
Killing assay | [90] | |
Clinical phenotype upon infection | [74] |